The European Union and UK-based drugs giant AstraZeneca settled their dispute over a shortfall in coronavirus vaccine supplies on Friday, agreeing an extended delivery schedule.
The European Commission went to court after the firm failed to deliver all of a promised 300 million doses by June 2021, but AstraZeneca will now have until the end of March next year to make up the number.
LONDON (AP) — German officials have decided to limit the use of AstraZeneca’s coronavirus vaccine in people under 60 after more unusual blood clots were reported in a small number of people who received the shots.
AstraZeneca reiterated on Wednesday that its Covid-19 vaccine was very effective at preventing the disease, based on more recent data than was included when the company announced the interim results of its U.S. clinical trial on Monday.
The company said in a news release that its vaccine was 76 percent effective at preventing Covid-19. That is slightly lower than the efficacy number that the company announced earlier this week.
